Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7588359

Concept 2022-03-01 to
2022-08-31
2021-03-01 to
2021-08-31
Consolidated statement of income
Statement of income
Net sales
59,619,000,000 JPY
58,551,000,000 JPY
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
69,000,000 JPY
151,000,000 JPY
Cost of sales
25,156,000,000 JPY
23,120,000,000 JPY
Operating expenses
Selling, general and administrative expenses
29,549,000,000 JPY
29,723,000,000 JPY
Operating expenses
Net sales
Gross profit (loss)
34,462,000,000 JPY
35,430,000,000 JPY
Operating profit (loss)
4,913,000,000 JPY
5,706,000,000 JPY
Ordinary profit (loss)
8,870,000,000 JPY
6,836,000,000 JPY
Operating expenses
Research and development expenses
4,935,000,000 JPY
5,011,000,000 JPY
Extraordinary income
142,000,000 JPY
659,000,000 JPY
Gain on disposal of non-current assets
142,000,000 JPY
6,000,000 JPY
Non-operating income
Interest income
202,000,000 JPY
79,000,000 JPY
Dividend income
501,000,000 JPY
479,000,000 JPY
Other
224,000,000 JPY
270,000,000 JPY
Non-operating income
4,074,000,000 JPY
1,356,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
5,573,000,000 JPY
5,710,000,000 JPY
Non-operating expenses
Interest expenses
4,000,000 JPY
6,000,000 JPY
Other
43,000,000 JPY
67,000,000 JPY
Non-operating expenses
118,000,000 JPY
226,000,000 JPY
Extraordinary losses
77,000,000 JPY
328,000,000 JPY
Loss on disposal of non-current assets
77,000,000 JPY
48,000,000 JPY
Gross profit
Profit (loss) before income taxes
8,935,000,000 JPY
7,168,000,000 JPY
Extraordinary income
Gain on sale of investment securities
JPY
652,000,000 JPY
Extraordinary losses
Income taxes
2,215,000,000 JPY
2,022,000,000 JPY
Profit (loss)
6,720,000,000 JPY
5,145,000,000 JPY
Profit (loss) attributable to non-controlling interests
215,000,000 JPY
143,000,000 JPY
Profit (loss) attributable to owners of parent
6,504,000,000 JPY
5,002,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,015,000,000 JPY
945,000,000 JPY
Foreign currency translation adjustment
12,996,000,000 JPY
4,273,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-160,000,000 JPY
-129,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-26,000,000 JPY
-79,000,000 JPY
Other comprehensive income
13,826,000,000 JPY
5,011,000,000 JPY
Profit attributable to
Comprehensive income
20,546,000,000 JPY
10,156,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
20,392,000,000 JPY
10,018,000,000 JPY
Comprehensive income attributable to non-controlling interests
153,000,000 JPY
138,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.